Industrial scale refers to the level of manufacturing capacity at which a biopharmaceutical process is operated to produce drug substance or drug product in quantities sufficient for commercial distribution and market supply. For CDMOs, industrial-scale manufacturing capability is a key competitive differentiator in supporting sponsors from Phase III clinical trials through to commercial launch.
